|
gptkbp:instanceOf
|
company
|
|
gptkbp:businessModel
|
laboratory services
patient empowerment
retail clinics
venture capital funding
partnerships with pharmacies
disruptive technology
rapid results
cost-effective testing
convenient testing locations
direct-to-consumer testing
scalable testing solutions
healthcare_innovation
|
|
gptkbp:CEO
|
gptkb:Elizabeth_Holmes
|
|
gptkbp:claims
|
revolutionary blood testing
|
|
gptkbp:controversy
|
fraud allegations
|
|
gptkbp:convictedOf
|
conspiracy to commit wire fraud
wire_fraud
|
|
gptkbp:court
|
gptkb:United_States_v._Elizabeth_Holmes
|
|
gptkbp:dissolved
|
2018
|
|
gptkbp:employees
|
800 (at peak)
|
|
gptkbp:filmography
|
gptkb:The_Inventor:_Out_for_Blood_in_Silicon_Valley
|
|
gptkbp:founded
|
2003
|
|
gptkbp:founder
|
gptkb:Elizabeth_Holmes
|
|
gptkbp:headCoach
|
200 (in 2018)
|
|
gptkbp:headquarters
|
gptkb:California
gptkb:Palo_Alto,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Theranos, Inc.
|
|
gptkbp:impact
|
regulatory changes
startup culture
investor scrutiny
media portrayal of entrepreneurs
public trust in healthcare startups
|
|
gptkbp:industry
|
healthcare
|
|
gptkbp:investmentFocus
|
gptkb:Ramesh_Balwani
gptkb:Henry_Kissinger
gptkb:Larry_Ellison
gptkb:Tim_Draper
Rupert Murdoch
David Boies
George Shultz
|
|
gptkbp:launchDate
|
August 2021
|
|
gptkbp:media_coverage
|
extensive
|
|
gptkbp:outcome
|
guilty verdicts
|
|
gptkbp:partnerships
|
gptkb:Walgreens
gptkb:Safeway
|
|
gptkbp:products
|
Edison_device
|
|
gptkbp:publishedBy
|
gptkb:Bad_Blood:_Secrets_and_Lies_in_a_Silicon_Valley_Startup
|
|
gptkbp:relationship
|
Elizabeth_Holmes_and_Ramesh_Balwani
|
|
gptkbp:revenue
|
$100 million (estimated)
|
|
gptkbp:status
|
defunct
|
|
gptkbp:technology
|
blood testing
|
|
gptkbp:values
|
$9 billion (at peak)
|
|
gptkbp:website
|
theranos.com
|